News Summary: Actavis to buy Forest Labs for $25B

Published on NewsOK Modified: February 18, 2014 at 3:57 pm •  Published: February 18, 2014

BIG DEAL: Ireland's Actavis is offering about $25 billion to buy Forest Laboratories of New York Inc. and leapfrog to become the world's No. 15 drugmaker by revenue.

THE RATIONALE: Actavis, which sells hundreds of generic, brand-name and nonprescription medicines, wants more new brand-name drugs to add to its portfolio. Forest has them, along with the big network of U.S. sales reps targeting family doctors that Actavis lacks.

NEW MODEL: Actavis, billed as a specialty drugmaker, now will have a good mix of primary care drugs and medicines for more complex disorders, plus it's developing similar versions of biologic drugs.


Trending Now


  1. 1
    Conservative Activist Claims Women Paid The Same As Men Won't Find Husbands
  2. 2
    Report: Thunder to open playoffs on Saturday
  3. 3
    Former Sonics guard Gary Payton: Durant, Westbrook 'the new era'
  4. 4
    GOP consulting firm employee starts 'Boats 'N Hoes PAC'
  5. 5
    Why One Man Traveled Almost 3,000 Miles To Take On The Federal Government At A Ranch In Nevada
+ show more